Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could probiotic pasta help fight obesity?

NCT ID NCT04962633

Disease control Sponsor: Federico II University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether eating probiotic-enriched pasta daily for 4 weeks could improve metabolic health and reduce inflammation in overweight and obese adults. Forty healthy men and women with a BMI between 25 and 35 ate either probiotic pasta or regular pasta. Researchers measured blood markers like cholesterol, glucose, and C-reactive protein, as well as gut health and body measurements.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
probiotic pasta
What this could lead to
If it works, this could point toward a simple dietary addition to help manage weight and reduce inflammation in overweight people.
What could go wrong
This is a small, short-term study (40 people, 4 weeks) with no blinding or long-term follow-up. Results may not be generalizable or clinically significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Jan 2022

Finished

Dec 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * healthy subjects; * men and women; * age 18-65 years; * 25 kg/m2 ≤ BMI ≤ 35 kg/m2; * habitual daily pasta consumption (≥ 1 portion/day); * habitual diet characterized by absence of any food supplements and alternative medication, probiotics and prebiotics, whole grain and/or fiber enriched foods; * intake of fruit/vegetables \< 3 servings/day; * low level of physical activity (\< 500 metabolic equivalent min/week); * signed written informed consent. Exclusion Criteria: * food allergies and intolerances and celiac disease; * gastrointestinal diseases; * relevant diseases; * pregnant or breastfeeding; * previous abdominal surgery; * hypertriglyceridemia (Triglycerides \> 200 mg/dL); * hypercholesterolemia (Total cholesterol \> 200 mg/dL); * hyperglycaemia (glycaemia ≥ 110 mg/dL); * hypertension (arterial blood pressure ≥140/90 mm Hg); * weight loss ≥ 3 kg within 2 months before the study; * antibiotics treatment within 3 months before the study; * any medication (different from antibiotics) at the enrollment and within 2 months before the study; * habitual diet characterized by high fruit and vegetables intakes (\>3 portion/die); * high level of physical activity; * Alcohol consumption ≥ 3 alcohol units per day; * simultaneous participation in other trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Overweight and obesity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Overweight and obesity

Contacts and locations

Locations

  • Department of Agricultural Sciences

    Portici, Italy, 80055, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.